Citi downgrades AstraZeneca (NYSE: AZN) from Buy to Hold.

Citi analyst says, "In a highly uncertain environment, the strong ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE